HEPATOMEGALY

Clinical trials for HEPATOMEGALY explained in plain language.

Never miss a new study

Get alerted when new HEPATOMEGALY trials appear

Sign up with your email to follow new studies for HEPATOMEGALY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New hope for patients with rare, Hard-to-Treat blood disorders

Disease control Recruiting now

This study is testing whether the drug ruxolitinib can help control rare blood disorders where the body makes too many eosinophils, a type of white blood cell. It will involve about 10 adults whose conditions have not responded well to standard treatments like steroids. The main …

Matched conditions: HEPATOMEGALY

Phase: PHASE2 • Sponsor: William Shomali • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

HEPATOMEGALY

Get alerted when new HEPATOMEGALY trials appear

New hope for patients with rare, Hard-to-Treat blood disorders